Skip to content
Buy This GLP
← Research
Formats

Does Sublingual Semaglutide Work? What the Research Shows

Animal studies tested formulations under the tongue. Published studies have not established how much drug people absorb from marketed compounded drops or whether they lose weight.

Editorial profile: Wesley JenkinsBuy This GLP Editorial Team4 min read
FDA-approved oral tabletsSwallowed and studied in peopleExperimental sublingual formulationsPublished results in rats and minipigs

The available evidence does not establish that compounded semaglutide drops taken under the tongue lead to weight loss in people. Studies of how semaglutide tablets and injections are absorbed apply to the products tested. They cannot tell us how much of a compounded drop reaches the bloodstream.[1][2][3][5]

How the approved tablets work

The U.S. Rybelsus and Ozempic tablet label says both contain an absorption enhancer called SNAC and are absorbed mainly in the stomach. The Wegovy label covers an injection and a swallowed tablet. These products have their own clinical data, which do not establish the effects of a formulation used under the tongue.[1][5]

The FDA concerns about compounded semaglutide apply to claims about product safety and effectiveness. FDA does not approve compounded drugs or review them for safety, effectiveness, or quality before marketing. If clinical data are cited, check whether the study tested that specific formulation in people.[6]

What animal studies measured

In a single-dose rat study, experimental formulations given under the tongue had about 0.29% to 0.34% of the dose-adjusted exposure of the injection. The authors worked for a supplier to compounding pharmacies. A different study used an investigational film in minipigs and found less weight gain than with placebo. The animals still gained weight. Neither study evaluated a marketed compounded drop in people.[2][3]

What online listings can show

A 2025 search of compounding websites found 17 single-ingredient semaglutide or tirzepatide products in formulations that differed from the approved versions. Of those listings, 82% were for products used under the tongue. The researchers reviewed product offerings and did not test their absorption or effect on weight.[4]

Frequently asked

Is there evidence that compounded semaglutide drops work?
Published human evidence has not established absorption or weight loss for marketed compounded drops. Animal results concern the specific experimental formulations that researchers tested.
Are semaglutide drops the same as the approved oral tablet?
Approved oral semaglutide is swallowed and formulated for absorption mainly in the stomach. Its clinical data do not establish the effects of compounded drops used under the tongue.

Sources

  1. [1] Novo Nordisk (2026). RYBELSUS and OZEMPIC (semaglutide) tablets, for oral use — prescribing information DailyMed, U.S. National Library of Medicine. Source
  2. [2] Liu Y, et al. (2026). Single-dose pharmacokinetics of sublingual semaglutide in rats European Journal of Pharmaceutical Sciences. PMID 41386332
  3. [3] Sagar G, et al. (2026). Electrospun Nanofiber Oral Thin Film Platform for Sublingual Peptide Delivery: A Promising Alternative to Conventional Semaglutide Formulations Diabetes, Obesity and Metabolism. PMID 42297758
  4. [4] Belcourt J, et al. (2026). Compounded Semaglutide and Tirzepatide Products Use Unique Formulations but Efficacy and Safety Largely Unknown Annals of Pharmacotherapy. PMID 41689811
  5. [5] Novo Nordisk (2026). WEGOVY (semaglutide) injection and tablets — prescribing information DailyMed, U.S. National Library of Medicine. Source
  6. [6] U.S. Food and Drug Administration (2026). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss U.S. Food and Drug Administration. Source

Where to get it

Price the oral sellers

Switch the desk to tablets and it prices the oral product itself, never a figure borrowed from the same seller's injection page.

Open the price desk →

More in Formats